Ampio Pharmaceuticals, Inc.

Ampio Pharmaceuticals, Inc.verified

AMPE

Price:

$0.25805

Market Cap:

$292.98K

Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an intravenous ampion treatment that is in Phase II clinical trial to treat adult COVID-19 patients requiring oxygen supplementation; AP-019, an Inhaled Ampion treatment, which is in Phase II clinical trial for the treatment of Adults with Respiratory Distress Due to COVID-19; and AP-018 that is in Phase I clinical trial to treat patients with prolonged...[Read more]

Industry

Biotechnology

IPO Date

2010-03-31

Stock Exchange

OTC

Ticker

AMPE

The ROE as of January 2026 (TTM) for Ampio Pharmaceuticals, Inc. (AMPE) is -113.96%

According to Ampio Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is -113.96%. This represents a change of 193.35% compared to the average of -38.85% of the last 4 quarters.

Ampio Pharmaceuticals, Inc. (AMPE) Historical ROE (quarterly & annually)

How has AMPE ROE performed in the past?

The mean historical ROE of Ampio Pharmaceuticals, Inc. over the last ten years is -39.25%. The current -113.96% ROE has changed 190.34% with respect to the historical average. Over the past ten years (40 quarters), AMPE's ROE was at its highest in in the September 2017 quarter at 2.13%. The ROE was at its lowest in in the March 2020 quarter at -259.86%.

Quarterly (TTM)
Annual

Average

-39.25%

Median

-88.64%

Minimum

-288.86%

Maximum

649.07%

Ampio Pharmaceuticals, Inc. (AMPE) ROE by Quarter and Year

Discovering the peaks and valleys of Ampio Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 327.49%

Maximum Annual ROE = 649.07%

Minimum Annual Increase = -152.56%

Minimum Annual ROE = -288.86%

Quarterly (TTM)
Annual
YearROEChange
2023-256.90%85.39%
2022-138.58%121.43%
2021-62.58%-31.05%
2020-90.76%-57.10%
2019-211.55%-132.59%
2018649.07%327.49%
2017151.83%-152.56%
2016-288.86%233.88%
2015-86.52%50.04%
2014-57.66%-20.56%

Ampio Pharmaceuticals, Inc. (AMPE) Average ROE

How has AMPE ROE performed in the past?

The current ROE of Ampio Pharmaceuticals, Inc. (AMPE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-152.69%

5-year avg

-152.07%

10-year avg

-39.25%

Ampio Pharmaceuticals, Inc. (AMPE) ROE vs. Peers

How is AMPE’s ROE compared to its peers?

Ampio Pharmaceuticals, Inc.’s ROE is greater than Better Therapeutics, Inc. (-221.99%), greater than Calithera Biosciences, Inc. (-131.13%), greater than Oncology Pharma Inc. (-19427.83%), less than Innovation1 Biotech Inc. (2.07%), greater than Panacos Pharmaceuticals, Inc. (-85.57%), less than Tengion, Inc. (188.30%), less than Statera Biopharma, Inc. (6.68%), less than Baudax Bio, Inc. (1.07%), less than Arno Therapeutics, Inc. (250.44%), greater than Kaleido Biosciences, Inc. (-580.57%),

Build a custom stock screener for Ampio Pharmaceuticals, Inc. (AMPE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ampio Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ampio Pharmaceuticals, Inc. (AMPE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ampio Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Ampio Pharmaceuticals, Inc.'s ROE?

How is the ROE calculated for Ampio Pharmaceuticals, Inc. (AMPE)?

What is the highest ROE for Ampio Pharmaceuticals, Inc. (AMPE)?

What is the 3-year average ROE for Ampio Pharmaceuticals, Inc. (AMPE)?

What is the 5-year average ROE for Ampio Pharmaceuticals, Inc. (AMPE)?

How does the current ROE for Ampio Pharmaceuticals, Inc. (AMPE) compare to its historical average?